Table 6. Patients’ ARV drug regimens.
| Regimen | ARV drugs | Number of Subjects | Prescriptions and refills (N, %) |
|---|---|---|---|
| R1 | AZT/3TC/NVP | 35 | 427 (35.29%) |
| R2 | TDF/3TC+NVP | 9 | 151 (12.48%) |
| R3 | TDF/3TC+EFV | 41 | 600 (49.58%) |
| R4 | AZT/3TC/EFV | 5 | 11 (0.9%) |
| R5 | TDF/3TC+ATV/r | 1 | 4 (0.33%) |
| R6 | TDF/3TC+/LPV/r | 1 | 5 (0.4%) |
| R7 | TDF/3TC+ABC+ LPV/r | 1 | 1 (0.08%) |
| R8 | AZT/3TC+/LPV/r | 1 | 10 (0.82%) |
| R9 | AZT/3TC | 1 | 1 (0.08%) |
Abbreviations: N: sample size; ARV: antiretroviral; AZT: zidovudine; 3TC: lamivudine; NVP: Nevirapine; TDF: tenofovir; EFV: efavirenz; ATV/r: atazanavir/ritonavir; LPV/r, lopinavir/ritonavir; ABC: abacavir.